CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	382K 335K 309K 289K 542K 36.05M 554K 3.71M 1.44M 17.82M 1.44M 1.4M 61.78M	P/E 2014	-2.3x	P/E 2015	-2.17x
Enterprise Value	539K 472K 435K 408K 764K 50.82M 780K 5.23M 2.02M 25.11M 2.02M 1.98M 87.09M	EV / Sales 2014	-	EV / Sales 2015	-
Free-Float	97.49%	Yield 2014 *	-	Yield 2015	-

21-09-09	Cardiogenics Holdings Inc Announces A Record Date Change for Its Dividend Distribution	CI
21-09-03	CardioGenics Holdings Inc. Announces License Agreement	CI
15-11-01	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI
15-10-04	CardioGenics Holdings Inc entered into a non-binding letter of intent to acquire substantially all of the assets of Plasticap Inc.	CI
15-01-12	CardioGenics Holdings Inc. Appoints Karim Murabet as Director	CI
13-09-27	CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013	CI
13-08-21	CardioGenics Holdings Inc Announces Commencement of Beta-Site Testing	CI
13-06-05	CardioGenics Holdings Inc Announces Internal Review Board Approval for Beta-Site Testing	CI
13-06-03	CardioGenics Holdings Inc announced that it has received $0.66 million in funding.	CI
13-05-31	CardioGenics Holdings Inc announced that it expects to receive $1.5 million in funding.	CI
13-02-28	CardioGenics Holdings Inc. Announces Demise of Director, Alexander D. G. Reid	CI
13-02-26	CardioGenics Holdings Inc. announced that it expects to receive $1 million in funding.	CI
12-04-17	CardioGenics Holdings Inc has Changed its Ticker to CGNH from CGNHE	CI

21-09-28	UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
21-09-09	CARDIOGENICS : ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION	AQ
21-09-03	CARDIOGENICS : ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION	AQ
15-11-04	CardioGenics : Enters Into Asset Purchase Agreement to Acquire All Assets of Ontario-Based Plasticap	MW
15-10-05	CardioGenics : Enters Into Binding Letter of Intent to Acquire Assets of Ontario-Based Plasticap	MW

Manager	Title	Age	Since
Yahia A. Gawad CEO	Chief Executive Officer	68	2009-10-26
James A. Essex DFI	Director of Finance/CFO	78	2010-06-15
Linda J. Sterling IRC	Investor Relations Contact	65	-

Director	Title	Age	Since
Yahia A. Gawad BRD	Director/Board Member	68	2011-04-05
Julian Neil Tabatznik CHM	Chairman	76	2010-06-15
Linda J. Sterling BRD	Director/Board Member	65	2010-06-15

CardioGenics Holdings Inc Stock Other OTC

Stocks

CGNH

US14160X2036

Medical Equipment, Supplies & Distribution

Valuation: CardioGenics Holdings Inc

Latest news : CardioGenics Holdings Inc

Press Releases: CardioGenics Holdings Inc

Quotes and Performance

Managers and Directors: CardioGenics Holdings Inc

Diagnostic & Testing Substances

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARDIOGENICS HOLDINGS INC	-35.19%	+110.24%	-	-	142
GUARDANT HEALTH, INC.	+4.39%	+13.23%	+198.26%	+318.33%	19.79B
BIOMÉRIEUX	+1.64%	+3.26%	-40.48%	-21.10%	9.59B
LANTHEUS HOLDINGS, INC.	+0.72%	+5.72%	+35.99%	+26.97%	7.15B
CARIS LIFE SCIENCES, INC.	-1.07%	+0.16%	-30.84%	-	5.23B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-0.45%	+0.93%	-26.06%	-30.95%	4.9B
10X GENOMICS, INC.	+2.85%	+5.74%	+214.10%	-32.99%	4.67B
ANDON HEALTH CO., LTD.	-7.42%	-9.54%	+84.88%	+90.76%	4.09B
DIASORIN S.P.A.	+2.92%	+5.04%	-27.30%	-28.26%	4.13B
AUTOBIO DIAGNOSTICS CO., LTD.	-2.97%	-5.81%	-23.00%	-45.43%	2.41B
Average	-3.46%	+2.14%	+42.84%	+34.67%	6.88B
Weighted average by Cap.	+1.42%	+5.38%	+75.57%	+108.06%

	2014	2015
Net sales	-	-
Net income	-2.68M -2.35M -2.17M -2.03M -3.8M -253M -3.88M -26.03M -10.07M -125M -10.06M -9.84M -433M	-1.92M -1.68M -1.55M -1.45M -2.72M -181M -2.78M -18.62M -7.2M -89.34M -7.2M -7.04M -310M
Net Debt	132K 116K 107K 100K 188K 12.47M 192K 1.28M 497K 6.17M 497K 486K 21.38M	157K 137K 126K 118K 222K 14.76M 227K 1.52M 588K 7.3M 588K 575K 25.3M